Remicade (infliximab) is now the first biologic approved for ulcerative colitis

Remicade (infliximab) is now the first biologic approved for ulcerative colitis in Canada.

It's for moderate to severe ulcerative colitis in patients who haven't responded to conventional therapy...5-ASA, steroids, etc.

Remicade can induce remission...prevent colectomy...and reduce or eliminate steroid use.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote